All In Biotech

Investigational drug · Phase 2

LY4515100

Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Acute Pain, Molar, Molar, Third.

Phase 2

Last checked: Nov 19, 2026Latest source record: May 1, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 2

Industry-sponsored trials

Phase 2 and 3 trials

1

1 still active

All registered trials

3

Any phase or sponsor naming "LY4515100"

First trial start

2026

Apr 1, 2026

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "LY4515100", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Acute Pain
  • Molar
  • Molar, Third
  • Surgery, Oral

Approved drugs for the same conditions: Acute pain · Pain and anesthesia

Largest trials

Live from ClinicalTrials.gov: studies naming "LY4515100" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 0 on PubMed

No PubMed records name it yet, which is common for early code-named drugs.

Also in development for Acute Pain

  • CebranopadolTRN-228Phase 34 trials

    Adneuris Therapeutics, Inc. · Pain, Acute Pain, Chronic Pain

  • MR-107A-02Phase 31 trial

    Viatris Specialty LLC · Acute Pain, Post Operative Pain, Pain

  • matched to VX-993Phase 22 trials

    Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain

  • VX-993Phase 22 trials

    Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain

  • GRT7040Phase 21 trial

    Grünenthal GmbH · Acute Pain, Bunionectomy

  • SRP-001Phase 21 trial

    South Rampart Pharma, Inc. · Acute Pain, Postoperative Pain, Pain

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do. More from Eli Lilly.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.